884 related articles for article (PubMed ID: 35951774)
1. The double-edged sword of probiotic supplementation on gut microbiota structure in
Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
[TBL] [Abstract][Full Text] [Related]
2. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Larabi A; Barnich N; Nguyen HTT
Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
[TBL] [Abstract][Full Text] [Related]
3. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal microbiome and
Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
[No Abstract] [Full Text] [Related]
5. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
6. Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.
Fang X; Miao R; Wei J; Wu H; Tian J
Comput Struct Biotechnol J; 2022; 20():5935-5951. PubMed ID: 36382190
[TBL] [Abstract][Full Text] [Related]
7. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.
Chen L; Xu W; Lee A; He J; Huang B; Zheng W; Su T; Lai S; Long Y; Chu H; Chen Y; Wang L; Wang K; Si J; Chen S
EBioMedicine; 2018 Sep; 35():87-96. PubMed ID: 30145102
[TBL] [Abstract][Full Text] [Related]
8. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
9. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
10. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
Futosi K; Fodor S; Mócsai A
Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
[TBL] [Abstract][Full Text] [Related]
12. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
13. Emerging views of mitophagy in immunity and autoimmune diseases.
Xu Y; Shen J; Ran Z
Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
[TBL] [Abstract][Full Text] [Related]
14. Biological drug and drug delivery-mediated immunotherapy.
Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W
Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408
[TBL] [Abstract][Full Text] [Related]
15. Changes in the Functional Potential of the Gut Microbiome Following Probiotic Supplementation during Helicobacter Pylori Treatment.
Oh B; Kim JW; Kim BS
Helicobacter; 2016 Dec; 21(6):493-503. PubMed ID: 26991862
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
[TBL] [Abstract][Full Text] [Related]
17. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
18. Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota.
He C; Peng C; Xu X; Li N; Ouyang Y; Zhu Y; Lu N
Helicobacter; 2022 Aug; 27(4):e12898. PubMed ID: 35531615
[TBL] [Abstract][Full Text] [Related]
19. Probiotics: a proactive approach to health. A symposium report.
Thomas LV; Suzuki K; Zhao J
Br J Nutr; 2015 Dec; 114 Suppl 1():S1-15. PubMed ID: 26548336
[TBL] [Abstract][Full Text] [Related]
20. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
